May 10 INV Metals Inc
* INV metals reports Q1/2017 results
* Q1 loss per share C$0.02 Source text for Eikon: Further company coverage:
CORRECTED-Germany's Merck gets EU backing for oral MS drug
FRANKFURT, June 23 Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral multiple sclerosis (MS) drugs in Europe, six years after its first attempt to launch the cladribine pill failed.